List of Excipients in API methenamine hippurate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing methenamine hippurate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Validus Pharmaceuticals LLC | HIPREX | methenamine hippurate | 30698-277 | FD&C YELLOW NO. 5 | |
| Validus Pharmaceuticals LLC | HIPREX | methenamine hippurate | 30698-277 | MAGNESIUM STEARATE | |
| Validus Pharmaceuticals LLC | HIPREX | methenamine hippurate | 30698-277 | POVIDONE | |
| Validus Pharmaceuticals LLC | HIPREX | methenamine hippurate | 30698-277 | SACCHARIN SODIUM | |
| Validus Pharmaceuticals LLC | HIPREX | methenamine hippurate | 30698-477 | FD&C YELLOW NO. 5 | |
| Validus Pharmaceuticals LLC | HIPREX | methenamine hippurate | 30698-477 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing methenamine hippurate
Detailed excipient profiles for methenamine hippurate
Excipient focus: CELLULOSE, MICROCRYSTALLINE
methenamine hippurate drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Jubilant Cadista Pharmaceuticals Inc | methenamine hippurate | 59746-797 |
| >Company | >Ingredient | >NDC |
methenamine hippurate drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: FD&C YELLOW NO. 5
methenamine hippurate drug variants containing FD&C YELLOW NO. 5
| Company | Ingredient | NDC |
|---|---|---|
| Validus Pharmaceuticals LLC | methenamine hippurate | 30698-277 |
| Validus Pharmaceuticals LLC | methenamine hippurate | 30698-477 |
| Leading Pharma LLC | methenamine hippurate | 69315-210 |
| >Company | >Ingredient | >NDC |
methenamine hippurate drug variants not containing FD&C YELLOW NO. 5
Excipient focus: FD&C YELLOW NO. 6
methenamine hippurate drug variants containing FD&C YELLOW NO. 6
methenamine hippurate drug variants not containing FD&C YELLOW NO. 6
Excipient focus: MAGNESIUM STEARATE
methenamine hippurate drug variants containing MAGNESIUM STEARATE
methenamine hippurate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
methenamine hippurate drug variants containing POVIDONE
methenamine hippurate drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Micro Labs Limited | methenamine hippurate | 42571-332 |
| AvPAK | methenamine hippurate | 50268-549 |
| American Health Packaging | methenamine hippurate | 60687-694 |
| Carilion Materials Management | methenamine hippurate | 68151-0984 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K29/32
methenamine hippurate drug variants containing POVIDONE K29/32
| Company | Ingredient | NDC |
|---|---|---|
| Carilion Materials Management | methenamine hippurate | 68151-0984 |
| >Company | >Ingredient | >NDC |
methenamine hippurate drug variants not containing POVIDONE K29/32
Excipient focus: POVIDONE K90
methenamine hippurate drug variants containing POVIDONE K90
| Company | Ingredient | NDC |
|---|---|---|
| Micro Labs Limited | methenamine hippurate | 42571-332 |
| AvPAK | methenamine hippurate | 50268-549 |
| American Health Packaging | methenamine hippurate | 60687-694 |
| >Company | >Ingredient | >NDC |
methenamine hippurate drug variants not containing POVIDONE K90
Excipient focus: SACCHARIN SODIUM
methenamine hippurate drug variants containing SACCHARIN SODIUM
methenamine hippurate drug variants not containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Micro Labs Limited | methenamine hippurate | 42571-332 |
| AvPAK | methenamine hippurate | 50268-549 |
| Jubilant Cadista Pharmaceuticals Inc | methenamine hippurate | 59746-797 |
| American Health Packaging | methenamine hippurate | 60687-694 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
methenamine hippurate drug variants containing SILICON DIOXIDE
methenamine hippurate drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
methenamine hippurate drug variants containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Jubilant Cadista Pharmaceuticals Inc | methenamine hippurate | 59746-797 |
| >Company | >Ingredient | >NDC |
methenamine hippurate drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
